Search

Your search keyword '"Yokoyama, Seiya"' showing total 150 results

Search Constraints

Start Over You searched for: Author "Yokoyama, Seiya" Remove constraint Author: "Yokoyama, Seiya" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
150 results on '"Yokoyama, Seiya"'

Search Results

4. Exercise Suppresses Head and Neck Squamous Cell Carcinoma Growth via Oncostatin M

8. One-hundred-nm-scale electronic structure and transport calculations of organic polymers on the K computer

12. Characterization and treatment of gemcitabine‐ and cisplatin‐resistant bladder cancer cells with a pan‐RAS inhibitor

13. Data from Predicted Prognosis of Patients with Pancreatic Cancer by Machine Learning

14. Supplementary table 4 from Predicted Prognosis of Patients with Pancreatic Cancer by Machine Learning

15. Supplementary table 1 from Predicted Prognosis of Patients with Pancreatic Cancer by Machine Learning

16. Supplementary table 3 from Predicted Prognosis of Patients with Pancreatic Cancer by Machine Learning

17. Supplementary table 2 from Predicted Prognosis of Patients with Pancreatic Cancer by Machine Learning

18. Supplementary figure 3 from Predicted Prognosis of Patients with Pancreatic Cancer by Machine Learning

19. Supplementary figure 1 from Predicted Prognosis of Patients with Pancreatic Cancer by Machine Learning

20. Supplementary figure 2 from Predicted Prognosis of Patients with Pancreatic Cancer by Machine Learning

21. Supplementary figure 4 from Predicted Prognosis of Patients with Pancreatic Cancer by Machine Learning

23. Favorable prognostic impact of phosphatase and tensin homolog alterations in wild-type isocitrate dehydrogenase and telomerase reverse transcriptase promoter glioblastoma

25. Identification of Neck Lymph Node Metastasis-Specific microRNA—Implication for Use in Monitoring or Prediction of Neck Lymph Node Metastasis.

26. Characterization and treatment of gemcitabine- and cisplatin-resistant bladder cancer cells with a Pan-RAS inhibitor

27. Molecular Genetic Profile of 300 Japanese Patients with Diffuse Gliomas Using a Glioma-tailored Gene Panel

28. Distribution and favorable prognostic implication of genomicEGFRalterations inIDH‐wildtype glioblastoma

29. Genome Editing Using Cas9 Ribonucleoprotein Is Effective for Introducing PDGFRA Variant in Cultured Human Glioblastoma Cell Lines.

30. Distribution and favorable prognostic implication of genomic EGFR alterations in IDH‐wildtype glioblastoma.

32. Prognostic impact of PDGFRA gain/amplification and MGMT promoter methylation status in patients with IDH wild-type glioblastoma

33. Molecular Evaluation of Endometrial Dedifferentiated Carcinoma, Endometrioid Carcinoma, Carcinosarcoma, and Serous Carcinoma Using a Custom-Made Small Cancer Panel

34. Detection of EGFR Mutation Distribution and Transcriptional Variants in IDH-Wildtype High-Grade Gliomas Using a Next-Generation Sequencing Oncopanel

37. A tailored next‐generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas

38. Next-Generation Sequencing Analysis of Endometrial Screening Liquid-Based Cytology Specimens A Comparative Study to Tissue Specimens

39. Predicted Prognosis of Patients with Pancreatic Cancer by Machine Learning

40. Analysis by Next-Generation Sequencing Panel Covered 60 Genes and 17 Microsatellite Foci in Endometrial Screening Liquid-Based Cytology Specimens A Comparative Study to Tissue Specimens

42. The Association of Peroxiredoxin 4 with the Initiation and Progression of Hepatocellular Carcinoma

43. Immunohistochemical expression of mucin antigens in gallbladder adenocarcinoma: MUC1-positive and MUC2-negative expression is associated with vessel invasion and shortened survival

48. TET1-mediated DNA hypomethylation regulates the expression of MUC4 in lung cancer

49. Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas

Catalog

Books, media, physical & digital resources